Life Sciences = Future. Jobs. Exports.
Has the Australian biotech sector the potential to fill some of the gaps left by the demise of traditional manufacturing areas?
This question, and more, will be answered at Australia’s premier biotech conference, AusBiotech 2014, which is being held at the Gold Coast Convention and Exhibition Centre from 29-31 October.
Australia’s window of mining-driven prosperity is closing and the country must now look to other industries for sustainability and growth. High-tech, knowledge-based industries are a good match for Australia’s skills in high-cost, low-volume manufacturing and the life sciences sector offers huge potential to fill the space left by the mining downturn. Australia already has existing prowess in the biotech and life sciences and now is the time to leverage this to our economy’s advantage.
However, moving from research through development to commercialisation is not simple and companies need access to corporate and commercial expertise and insight. Technological innovation, knowledge and networking will be the the drivers of this evolution and all of these attributes will be found at AusBiotech 2014.
Held annually, AusBiotech informs and updates the biotechnology sector with current industry facts and knowledge. It provides key presentations and forums to help bring together representatives and professionals from across the biotechnology industry and the globe to experience a comprehensive conference program, extensive bio-industry exhibition, business matching program and associated events such as the AusFoodtech Symposium.
This year’s AusBiotech conference theme - Life Sciences = Future. Jobs. Exports - brings focus to the developments in biotechnology and the life sciences industry that will significantly boost Australia’s economic performance and help to build the nation.
Opening address | Hon. Ian Walker MP | Minister for Science, Information Technology, Innovation and the Arts |
Accessing innovation around the world | Dr Sue Dillon | Global Therapeutic Area Head for Immunology for Janssen |
The challenges for pharma and biotech in emerging markets - Focus on China and India | Prof Ian Edvalson | Partner, Wilson Sonsini Goodrich Rosati |
The connection between medical research and business | Prof Frank Gannon | Director and CEO, QIMR Berghofer Medical Research Institute |
The use and future development of biomarkers | Professor Yongzhang Luo | Founder and Chief Scientist, Protgen Ltd |
Bench marking biotech: Initiatives for the development of the biotechnology sector in Asia Pacific and their impact | Rhenu Bhuller | Senior Vice President, Healthcare, Frost & Sullivan |
Investors unplugged | Chair: Lawrence Gozlan | Chief Executive Officer, Scientia Capital |
Global regulatory issues | Chair: Bernard O'Shea | Partner Norton Rose Fulbright |
New economy, new manufacturing | Chair: Julie Phillips | Chief Executive Officer, BioDiem |
What does success look like? | Chair: Rob McInnes | Partner DibbsBarker |
What are we doing for commercialisation in Australia? | Chair: Helen Fisher | Leader - Life Sciences, Deloitte Australia |
Translation from innovation to the clinic and beyond | Chair: Dr Mark Ashton | Senior Director, Commercial Engagement, Health, UniQuest |
Focus on China | Chair: Glenn Cross | Chief Operating Officer, AusBiotech |
Converging the relationship between industry, investors and academia | Chair: Dr Anna Lavelle | Chief Executive Officer, AusBiotech |
The changing face of big pharma | Chair: Glenn Cross | Chief Operating Officer, AusBiotech |
Introduction of biosimilars into Australia | Chair: Dr Chris Holloway | Founder and Group Director of Regulatory Affairs, ERA Consulting Group |
Partnering program
AusBiotech’s Business Matching Program will facilitate more than 2500 meeting requests between participants from the biotechnology, biopharmaceutical, life sciences, business, investment, research and health industries.
AusBiotech 2014 will be utilising a networking and partnering platform for all participants of the AusBiotech national conference. The powerful application is an integrated mobile event application and business partnering system all in one that will provide delegates with a one-stop shop for all conference information and networking aspects at the conference.
The 2014 AusBiotech platform features:
- Ability to request and schedule 30-minute meetings with other attendees through the AusPartnering system.
- Access to the full program and associated networking events.
- Ability to view the profiles for all attendees - including, speakers, sponsors, exhibitors and attendees.
- Manage a personalised calendar of sessions, meetings and networking events.
- Receive important updates and announcements in the lead-up to and during AusBiotech 2014.
The platform can be utilised via your desktop or mobile device, making it easy to continue to interact in real time as you keep updated with the latest information at the conference.
All full conference attendees have been able to gain access into the AusPartnering system since the end of September 2014.
Public forum - can we make brain diseases of ageing a thing of the past?
‘Perspectives on dementia and Alzheimer’s and biotechnology’s role in treatments and prevention’ is a free event for the public to join and hear from a number of experts who will present their vision on what the future of cognitive diseases like dementia and Alzheimer’s looks like.
The forum will be held on Friday, 31 October from 9.45 am to noon. All attendees must have their AusBiotech 2014 conference registration, exhibitor pass or public forum pass to attend.
Concurrent agriculture and food biotechnology symposium
Where is Australia’s global niche?
- Thursday 30 - Friday 31 October 2014 | 9 am - noon
- Room 8, Gold Coast Convention & Exhibition Centre
- More information and registration: ausbiotechnc.org/program14/AFBS
This two-day agriculture and food biotechnology symposium will highlight how Australian food and agricultural companies can capitalise on biotechnology innovations by exploring:
- Macroeconomics of influencing Australia’s agri-bio industry.
- Technological advances that will transform livestock, horticulture and cropping industries.
- How to navigate regulatory and legal barriers.
- Emerging and enabling biotechnologies.
An outstanding line-up of international and national speakers from research and development, business, commercialisation, and legal and regulatory backgrounds will explain how Australia’s food and agri-bio industry can secure its future as a niche provider of technology, services and products and how Australian food and agri-bio companies can position themselves as the preferred providers.
AusBiotech 2014
29-31 October 2014
Gold Coast Convention and Exhibition Centre
More information:ausbiotechnc.org/#
Registration: ausbiotechnc.org/registration
The need for quality assurance in histopathology laboratories
In histopathology laboratories, where tests are considered the gold standard for diagnosing...
Avoid adverse regulatory action with comprehensive quality
Attention to detail is par for the course within most modern industries and fields, including...
The politics of health: how elections will impact on life sciences
With elections this year in the US, the UK and India — all major players in the life...